Specific long-term therapy may not prevent fractures in older women
Osteoporosis is a disease that causes thinning of the bones, loss of bone density, and increasingly fragile bones. This puts people at higher risk for bone fractures. Risk for the disease increases as we age. In fact, 50% of women over the age of 50 will experience a bone facture due to osteoporosis.
By 2020, an estimated 61 million American adults will have low bone mineral density. A group of medications known as "bisphosphonates" are sometimes used to treat osteoporosis. These medications increase bone mineral density, which strengthens bones and is thought to make them less likely to fracture. Studies have shown that the risk for bone fractures lessens when women with low bone mineral density take these medications for between 1 and 4 years. However, little is known about whether taking bisphosphonates for longer periods of time has the same effect.
Recently, a team of researchers examined whether older women taking bisphosphonates for 10-13 years had fewer bone fractures than older women with similar fracture risks who took these medicines only briefly. Their study was published in the Journal of the American Geriatrics Society.The research team examined data from the Women's Health Initiative study, a large study that began in 1993 to develop ways to reduce heart disease, cancer, and fractures in women after menopause. The researchers looked at information from 5,120 women within the study. These women were bisphosphonate users with a high risk for bone fractures.
More than 95% of participants in the study were over age 70, with an average age of about 80. The length of time the women had taken bisphosphonates when the study started was as follows:
- 13% for 2 years
- 34% for 3-5 years
- 20% for 6-9 years
- 33% for 10-13 years
The researchers followed the women in the study for nearly 4 years. They discovered that women who took bisphosphonates for 10-13 years had higher fracture rates, compared with women who took the medication for 2 years. Taking bisphosphonates for 3-9 years was not linked to a higher fracture risk.
"Our study and several others have found higher risk of fractures among very long-term bisphosphonate users, compared with short-term users. However, the ideal length of bisphosphonate use has not yet been studied in randomized clinical trials, which are considered the gold standard of research studies. Therefore, long-term bisphosphonate users should see their healthcare providers regularly to decide how long to continue bisphosphonate therapy in their individual cases," stated Rebecca L. Drieling, MPH, an author of the study.
This summary is from "Long-term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative." It appears online ahead of print in the March 2017 issue of the Journal of the American Geriatrics Society. The study authors are Rebecca L. Drieling, MPH, PHD; Andrea Z. LaCroix, PhD, MPH; Shirley A.A. Beresford, PhD, MS; Denise M. Boudreau, RPH, PhD, MS; Charles Kooperberg, PhD; Rowan T. Chlebowski, MD, PhD; Marcia G. Ko, MD; and Susan R. Heckbert, MD, PhD.
About the Health in Aging Foundation
This research summary was developed as a public education tool by the Health in Aging Foundation. The Foundation is a national non-profit established in 1999 by the American Geriatrics Society to bring the knowledge and expertise of geriatrics healthcare professionals to the public. We are committed to ensuring that people are empowered to advocate for high-quality care by providing them with trustworthy information and reliable resources. Last year, we reached nearly 1 million people with our resources through HealthinAging.org. We also help nurture current and future geriatrics leaders by supporting opportunities to attend educational events and increase exposure to principles of excellence on caring for older adults. For more information or to support the Foundation's work, visit http://www.HealthinAgingFoundation.org.
About the Journal of the American Geriatrics Society
Included in more than 9,000 library collections around the world, the Journal of the American Geriatrics Society (JAGS) highlights emerging insights on principles of aging, approaches to older patients, geriatric syndromes, geriatric psychiatry, and geriatric diseases and disorders. First published in 1953, JAGS is now one of the oldest and most impactful publications on gerontology and geriatrics, according to ISI Journal Citation Reports®. Visit wileyonlinelibrary.com/journal/JGS for more details.
About the American Geriatrics Society
Founded in 1942, the American Geriatrics Society (AGS) is a nationwide, not-for-profit society of geriatrics healthcare professionals that has–for 75 years–worked to improve the health, independence, and quality of life of older people. Its nearly 6,000 members include geriatricians, geriatric nurses, social workers, family practitioners, physician assistants, pharmacists, and internists. The Society provides leadership to healthcare professionals, policymakers, and the public by implementing and advocating for programs in patient care, research, professional and public education, and public policy. For more information, visit AmericanGeriatrics.org.
Daniel E Trucil
Related Journal Article